Debra L. Mohler and Gang Shen
Org. Biomol. Chem., 2006,4, 2082-2087
DOI:
10.1039/B600848H,
Communication
Heterodimeric compounds based on tethering the PPARγ agonist Rosiglitazone to the RXR ligand Targretin have been prepared.